Evidence map›Paper›PMID 33669156›Full record

ReviewInternational journal of molecular sciences2021

MicroRNA-mRNA Networks in Pregnancy Complications: A Comprehensive Downstream Analysis of Potential Biomarkers.

Asghar Ali, Frieder Hadlich, Muhammad W Abbas, Muhammad A Iqbal, Dawit Tesfaye, Gerrit J Bouma, Quinton A Winger, Siriluck Ponsuksili

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. MicroRNA Associations with Preterm Labor-A Systematic Review.International journal of molecular sciences · 2024
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. PCYT1B-Targeting miRNAs as Potential Biomarkers for Placental Diseases.International journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Asghar AliLeibniz Institute for Farm Animal Biology, Institute of Genome Biology, 18196 Dummerstorf, Germany.ORCID 0000-0002-5137-2547
Frieder HadlichLeibniz Institute for Farm Animal Biology, Institute of Genome Biology, 18196 Dummerstorf, Germany.
Muhammad W AbbasDepartment of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.
Muhammad A IqbalLeibniz Institute for Farm Animal Biology, Institute of Genome Biology, 18196 Dummerstorf, Germany.
Dawit TesfayeAnimal Reproduction and Biomedical Laboratory, Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Gerrit J BoumaAnimal Reproduction and Biomedical Laboratory, Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Quinton A WingerAnimal Reproduction and Biomedical Laboratory, Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Siriluck PonsuksiliLeibniz Institute for Farm Animal Biology, Institute of Genome Biology, 18196 Dummerstorf, Germany.ORCID 0000-0003-4714-1057
Research Institute for Farm Animal Biology (FBN) · DEColorado State University · USGovernment College University, Faisalabad · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnancy complications are a major cause of fetal and maternal morbidity and mortality in humans. The majority of pregnancy complications initiate due to abnormal placental development and function. During the last decade, the role of microRNAs (miRNAs) in regulating placental and fetal development has become evident. Dysregulation of miRNAs in the placenta not only affects placental development and function, but these miRNAs can also be exported to both maternal and fetal compartments and affect maternal physiology and fetal growth and development. Due to their differential expression in the placenta and maternal circulation during pregnancy complications, miRNAs can be used as diagnostic biomarkers. However, the differential expression of a miRNA in the placenta may not always be reflected in maternal circulation, which makes it difficult to find a reliable biomarker for placental dysfunction. In this review, we provide an overview of differentially expressed miRNAs in the placenta and/or maternal circulation during preeclampsia (PE) and intrauterine growth restriction (IUGR), which can potentially serve as biomarkers for prediction or diagnosis of pregnancy complications. Using different bioinformatics tools, we also identified potential target genes of miRNAs associated with PE and IUGR, and the role of miRNA-mRNA networks in the regulation of important signaling pathways and biological processes.

Indexed as

BiomarkersFemaleFetal Growth RetardationGene OntologyHumansMicroRNAsPlacenta DiseasesPlacentationPre-EclampsiaPregnancyPregnancy ComplicationsRNA, MessengerSignal TransductionTranscriptomeBiomarkersMicroRNAsMIRN210 microRNA, humanRNA, Messengerbiomarkersintrauterine growth restrictionmiR-210miRNAspreeclampsia

Identifiers

PMID33669156
PMCPMC7956714
OpenAlexW3133055909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.